Sponsored by AbbVie Medical Affairs and Ironwood Pharmaceuticals Intended for Physicians
Chapter 1
Strategies to Improve Diagnosis of Pediatric Functional Constipation (FC)
Chapter 2
Constipation Diagnostic Approach
Chapter 3
Management Strategies:
Non-Pharmacological Interventions
Chapter 4
Management Strategies: Novel Therapeutic Interventions
Chapter 5
Explore Patient-Centered Management Strategies for Pediatric FC
Linaclotide Indications, Important Safety Information, and Boxed Warning
Linaclotide is indicated for the treatment of:
- Irritable bowel syndrome with constipation (IBS-C) in adults
- Chronic idiopathic constipation (CIC) in adults
- Functional constipation (FC) in pediatric patients 6 to 17 years of age
IMPORTANT SAFETY CONSIDERATIONS AND BOXED WARNING
WARNING: RISK OF SERIOUS DEHYDRATION IN PEDIATRIC PATIENTS LESS THAN 2 YEARS OF AGE
Linaclotide is contraindicated in patients less than 2 years of age; in nonclinical studies in neonatal mice, administration of a single, clinically relevant adult oral dose of linaclotide caused deaths due to dehydration.
Chapters
Coming up next in 0:00
Watched
Placeholder
Strategies to Improve Diagnosis of Pediatric Functional Constipation (FC)
Chapter 1 | 12m 18s


Coming up next in 01:05
Watched
Placeholder
Constipation Diagnostic Approach
Chapter 2 | 17m 10s


Coming up next in 00:00
Watched
Placeholder
Management Strategies:
Non-Pharmacological Interventions
Chapter 3 | 14m 10s


Coming up next in 00:00
Watched
Placeholder
Management Strategies: Novel Therapeutic Interventions
Chapter 4 | 12m 34s


Coming up next in 00:00
Watched
Placeholder
Explore Patient-Centered Management Strategies for Pediatric FC
Chapter 5 | 31m 43s


Program Objectives
Discuss strategies to improve diagnosis of pediatric functional constipation (FC).
Review current and emerging treatments for pediatric FC.
Explore patient-centered management for pediatric FC.
Clinical Perspectives Presented by:
Bruno Chumpitazi, MD
Duke University
School of Medicine
Julie Khlevner, MD
Columbia University
Irving Medical Center
Sharon Perry, CNP
University Hospitals – Rainbow
Babies and Children’s Hospital